SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,515.43 362.57
( 0.48%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

65,002.68 788.20
(1.23%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.73 -0.22
(-0.23%)

EUR-INR

109.71 -0.40
(-0.36%)

GBP-INR

127.83 -0.65
(-0.50%)

JPY-INR

0.59 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9540829

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

145.16

96322.06

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.69

Back

Bang Overseas consolidated net profit rises 45.66% in the March 2026 quarter

May 30,2026

Net profit of Bang Overseas rose 45.66% to Rs 2.52 crore in the quarter ended March 2026 as against Rs 1.73 crore during the previous quarter ended March 2025. Sales rose 20.35% to Rs 58.07 crore in the quarter ended March 2026 as against Rs 48.25 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 5.95 crore in the year ended March 2026 as against net loss of Rs 2.17 crore during the previous year ended March 2025. Sales rose 18.59% to Rs 223.94 crore in the year ended March 2026 as against Rs 188.83 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	58.07	48.25	20	223.94	188.83	19
OPM %	7.04	4.33	-	3.63	-1.62	-
PBDT	4.16	2.14	94	7.84	-2.58	LP
PBT	3.87	1.79	116	6.54	-3.99	LP
NP	2.52	1.73	46	5.95	-2.17	LP

76,515.43 362.57 ( 0.48%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

65,002.68 788.20 (1.23%)

10,828.70 -2.82 (-0.03%)

94.73 -0.22 (-0.23%)

109.71 -0.40 (-0.36%)

127.83 -0.65 (-0.50%)

0.59 0.00 (0.14%)